← Companies|Newron Pharma
NW

Newron Pharma

NWRN.MI·BITMilan ITFounded 199940 employees
Micro CapbiotechPublicCNS
Platform: Evenamide Schiz
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (NWRN.MI)
Loading NWRN.MI stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ZanutinibNWR-1131Approved1Fusion ProteinLAG-3PI3KiADHDWet AMD
SemazanubrutinibNWR-247Phase 32RadioligandTROP-2Anti-TauParkinson'sCervical Ca
SEC Filings & Financial Documents
SEC filings are not available for BIT-listed companies.
Newron Pharma trades on BIT (IT). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)
2026-08-10
Semazanubrutinib Ph3 Readout
Cervical Ca
Ph3 Readout
2026-10-14
Zanutinib Ph3 Readout
ADHD
Ph3 Readout
2028-06-23
Semazanubrutinib Ph3 Readout
Parkinson's
Ph3 Readout